Pfizer Inc. (NYSE:PFE) is listed as one of the 13 Best Fortune 500 Dividend Stocks to Invest In. The company raised its Adjusted Diluted EPS guidance and expanded its cost-cutting plan, aiming for $7.7 billion in savings by 2027. Q2 2025 saw a 10% revenue increase to $14.7 billion, driven by strong demand for Vyndaqel drugs.

Pfizer Inc. (NYSE:PFE) reported a 10% revenue growth in Q2 2025, reaching $14.7 billion. The company raised its full-year adjusted diluted EPS guidance to $2.90-$3.10 and increased its cost-cutting goal to $7.7 billion by 2027. Pfizer anticipates $4.5 billion in savings by the end of 2025, largely driven by strong demand for its drugs.

Pfizer Inc. (NYSE:PFE) leads the list of 13 best Fortune 500 dividend stocks with a 7.20% dividend yield. The global pharmaceutical and biotechnology corporation, established in 1849, focuses on developing medicines and vaccines for various therapeutic areas like oncology and cardiology.

Pfizer Inc. (NYSE:PFE) is headquartered in New York and has a long history of developing pharmaceuticals and vaccines. While it offers an attractive dividend yield, some believe that certain AI stocks present greater upside potential. Check out a free report on the best short-term AI stock for more information.

Read more at Yahoo Finance: Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal